In the realm of injectable drug delivery, achieving ultra-precise dosing has long been a significant challenge. Traditional systems often struggle with accuracy, potentially leading to under- or over-medication, which can have serious implications for patient health. This issue is compounded by the need for devices that are both reliable and compact, capable of delivering consistent doses over extended periods without frequent maintenance or replacement.

Piezo actuators emerge as a groundbreaking solution to these challenges. By leveraging their unique properties, these actuators enable the development of injection systems that deliver medications with unprecedented accuracy. Their rapid response and fine control capabilities ensure that each dose is precisely measured and swiftly administered, significantly reducing the margin for error.

For piezo injectable device applications, we recommend the Boréas Technologies BOS1931. This single-chip driver delivers high-voltage, low-power performance with advanced features like energy recovery, differential output, and waveform synthesis. Compact and efficient, the BOS1931 supports capacitive loads up to 820 nF and operates within a 3–5.5 V supply range. Its fast startup time and multi-actuator synchronization make it ideal for precise, responsive systems, including haptic feedback, microfluidics, and compact actuation solutions.